Strategies for Determining the Mechanisms of Toxicity

References

• Task Force on Environmental Cancer and Heart and Lung Disease, Summary of the Workshop on Exposure to Environmental Agents, Their Metabolism, and Mechanisms of Toxicity: Research Needs. Report to Task Force by the Project Group on Exposure and Metabolic Mechanisms 1981
   Google Scholar
• Task Force on Environmental Cancer and Heart and Lung Disease, Position papers developed from the Workshop on Exposure to Environmental Agents, Their Metabolism, and Mechanisms of Toxicity. J. Environ. Scl. Health 1982; A17(4)447–608
   Google Scholar
• Nebert D. W. The importance of genetics in the metabolism and fate of mutagens and promutagens. J. Environ. Scl. Health 1982; A17: 559–566
   Google Scholar
• Wolf F. J. Effect of overloading pathways on toxicity. J. Environ. Pathol. Toxicol. 1980; 2: 113–134
   Google Scholar
• Brown C. C., Kozlol J. A. Statistical aspects of the estimation of human risk from suspected environmental carcinogens. SIAM Rev. 1983; 25(2)151–181
   Web of Science ®Google Scholar
• Krewski D., Crump K. S., Farmer J., Gaylor D. W., Howe R., Portier C., Salsburg D., Slelken R. L., Van Ryzin J. A comparison of statistical methods for low dose extrapolation utilizing time-to-tumor data. Fundam. Appl. Toxicol 1983; 3: 140–160
   PubMedGoogle Scholar
• Krewski D., Brown C., Murdoch D. Determining “safe” levels of exposure: Safety factors or mathematical models. Fundam. Appl. Toxicol. 1984; 4: S383–S394
   PubMedGoogle Scholar
• Lehman A. J., Vorhes F. A., Jr., Ramsey L. L. Appraisal of the safety of chemicals In foods, drugs, and cosmetics. Association of Food and Drug Officials of the United States (AFDOUS). 1959
   Google Scholar
• National Academy of Sciences. Estimation of Risk to Human Health. The Effects of Nitrate, Nitrite, and N-nitroso Compounds. National Academy Press, Washington, D.C. 1981
   Google Scholar
• National Academy of Sciences. The Nature of Risk Assessment. Risk Assessment In the Federal Government. Managing the Process. National Academy Press, Washington, D.C. 1983
   Google Scholar
• Gillette J. R. Problems in risk assessment. J. Environ. Sci. Health 1982; A17: 553–558
   Google Scholar
• Gillette J. R., Estabrook J. R. Evaluation of Xenoblotic Metabolism. Principles for the Evaluation of Toxic Hazards to Human Health, R. Tardlff, J. Rodericks. Plenum Press, New York, In press
   Google Scholar
• Brash D. C. Role of gene expression in mechanisms of toxicity/ carcinogenicity relative to environmental cancer, heart, and lung disease. J. Environ. Sci. Health 1982; A17(4)589–598
   Google Scholar
• Trosko J. E. Potential role of mutations and Inhibited intercellular communication in the genesis of some chronic diseases. J. Environ. Sci. Health 1982; A17(4)604–608
   Google Scholar
• Marx J. L. Do tumor promoters affect DNA after all. Science 1983; 219: 158–159
   PubMed Web of Science ®Google Scholar
• Miller E. C., Miller J. A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 1981; 47: 2327–2345
   PubMed Web of Science ®Google Scholar
• Hart R. W. Approaches to the study of the sequential events governing the Induction and fixation of genotoxic events: An overview. J. Am. Coll. Toxicol. 1983; 12: 1–5
   Google Scholar
• National Academy of Sciences. Report of the Research Briefing Panel on Human Health Effects of Hazardous Chemical Exposures. National Academy Press, Washington, D.C. 1983; 3
   Google Scholar
• McQueen C. A., Williams G. M. The use of cells from rat. mouse, hamster, and rabbit in the hepatocyte primary culture/ DNA-repalr test, Ann. New York Acad. Sci. 1983; 119–130
   Google Scholar
• Welsburger J. H., Williams G. M. The decision-point approach for systematic carcinogen testing. Food Cosmet. Toxicol. 1981; 19: 561–566
   PubMedGoogle Scholar
• Slvak A. An evaluation of assay procedures for detection of tumor promoters. Mutat. Res. 1982; 98: 377–387
   PubMed Web of Science ®Google Scholar
• Trosko J. E., Jones C., Aylsworth C., Tsuchimoto G. Elimination of metabolic cooperation is associated with the tumor promoters, oleic acid, and anthralin. Carcinogenesis 1982; 3: 1101–1103
   PubMed Web of Science ®Google Scholar
• Rivedal E., Sanner T. Promotional effect of different phorbol esters on morphological transformation of hamster embryo cells. Cancer Lett. 1982; 17: 1–8
   PubMed Web of Science ®Google Scholar
• Williams G. M. Epigenetic effects of liver tumor promoters and implications for health effects. Environ. Health Perspect. 1983; 50: 177–183
   PubMed Web of Science ®Google Scholar
• Ward J. M., Griesemer R. A., Weisburger E. K. The mouse liver tumor as an endpoint in carcinogenesis tests. Toxicol. Appl. Pharmacol. 1979; 51: 389–397
   PubMed Web of Science ®Google Scholar
• Harlan W. R., Sharrett A. R., Weil H., Turino G. M., Borhani N., Resnekov L. Impact of environment on cardiovascular disease. Report to the American Heart Association Task Force on Cardiovascular Disease. Circulation 1981; 63: 243A–246A
   PubMed Web of Science ®Google Scholar
• Kopp S. J., Glonek T., Perry H. M., Erlanger M., Perry E. F. Cardiovascular actions of cadmium at environmental exposure levels. Science 1982; 217: 837–839
   PubMed Web of Science ®Google Scholar
• Turino G. M. Effect of carbon monoxide on the cardiorespiratory system. Carbon monoxide toxicity: Physiology and biochemistry. Circulation 1981; 63: 253A–259A
   PubMed Web of Science ®Google Scholar
• Corbett S. C., Cartwright R. A. Neoplasia of the arterial wall: Role In atherosclerosis. Medical Hypotheses 1980; 6: 389–400
   PubMed Web of Science ®Google Scholar
• Trosko J. E., Chang C. C. An integrative hypothesis linking cancer, diabetes and atherosclerosis: The role of mutagens and epigenetic changes. Medical Hypotheses 1980; 6: 455–468
   PubMed Web of Science ®Google Scholar
• Nelson N. A., Kelly R. C., Johnson R. A. Prostaglandins and the arachidonic acid cascade. Chem. Eng. News 1982; 60(33)30–44
   Web of Science ®Google Scholar
• Pfeffer M. A., Pfeffer J. M., Lewis R. A., Braunwald E., Corey E. J., Austen K. F. Systemic hemodynamic effects of leukotrienes C4 and D4 in the rat. Am. J. Physiol. Heart Circ. Physiol. 1983; 13: H628–H633
   Google Scholar
• Task Force on Environmental Cancer and Heart and Lung Disease, Workshop on Environmentally Related Nononcogenic Lung Disease, Warrenton, Virginia, March 13–18, 1983. Env. Res. 1985; 37(2)
   Google Scholar
• Biagini R. E., Moorman W. J., Smith R. J., Lewis T. R., Bernstein I. L. Pulmonary hyperreactivity in cynomolgus monkeys (Macaca fasicularls) from nose-only inhalation exposure to disodium hexachloroplatinate (Na2PtC1b). Toxicol. Appl. Pharmacol. 1983; 69: 377–384
   PubMed Web of Science ®Google Scholar
• Becklake M. R. Exposure to asbestos and human disease. New Engl. J. Med. 1982; 306: 1480–1482
   PubMed Web of Science ®Google Scholar
• Craighead J. E., Mossman B. T. The pathogenesis of asbestos-associated diseases. New Engl. J. Med. 1982; 306: 1446–1455
   PubMed Web of Science ®Google Scholar
• Craighead J. E., Abraham J. L., Churg A., Green F. H.Y., Klelnerman J., Pratt P. C., Seemayer T. A., Vallyathan V., Weill H. The pathology of asbestos-associated diseases of the lung and pleural cavities. Arch. Pathol. Lab. Med. 1984; 103(1)93
   Google Scholar
• International Labor Organization. Guidelines for the Use of the ILO International Classification of Radiographs of Pneumoconioses. International Labor Organization, Geneva 1980; 1–48, Occupational Health and Safety Series No. 22
   Google Scholar
• Miller E. C., Miller J. A. Mechanisms of chemical carcinogenesis. Cancer 1981; 47: 1055–1064
   PubMed Web of Science ®Google Scholar
• Hammond P. B., Bellies R. P. Metals. Toxicology, J. Doull, CD. Klaassen, M. O. Amdur. Macmillan, New York 1980; 421–428
   Google Scholar
• Welsburger J. H., Williams G. M. Carcinogen testing: Current problems and new approaches. Science 1981; 214: 401–407
   PubMed Web of Science ®Google Scholar
• Myers M. C., Kanerva R. L., Alden C. L., Anderson R. L. Reversibility of nephrotoxicity induced in rats by nitrllo-triacetate In subchronlc feeding studies. Food Chem. Toxicol. 1982; 20: 925–934
   PubMed Web of Science ®Google Scholar
• Conney A., Levin W. Carcinogen Metabolism in Experimental Animals and Man. Chemical Carcinogenesis Essays, R. Monte-sano, L. Tomatls. IARC WHO, Lyon 1974; 3–24
   Google Scholar
• Boyd M., Statham C. The effect of hepatic metabolism on the production and toxicity of reactive metabolites in extrahepatic organs. Drug Metab. Rev. 1983; 14: 35–47
   PubMed Web of Science ®Google Scholar
• Snyder R., Sammett D., Witmer C., Koesls J. J. An Overview of the Problem of Benzene Toxicity and Some Recent Data on the Relationship of Benzene Metabolism to Benzene Toxicity. Genotoxic Effects of Airborne Agents, R. R. Trice, D. L. Costa, K. M. Schaicl. Plenum Press, New York 1982; 225–240
   Google Scholar
• Bus J., Gibson J. Mechanisms of superoxide radical-mediated toxicity. J. Toxicol. Clin. Toxicol. 1982–3; 19: 689–697
   PubMed Web of Science ®Google Scholar
• Samuelsson B. Leukotrienes, Mediators of immediate hypersensitivity reactions and Inflammation. Science 1983; 220: 568–574
   PubMed Web of Science ®Google Scholar
• Kuehl F. A., Egan R. W. Prostaglandins, arachldonic acid and inflammation. Science 1980; 210: 978–984
   PubMed Web of Science ®Google Scholar
• Meister A. Selective modification of glutathione metabolism. Science 1983; 220: 470–477
   Web of Science ®Google Scholar
• Weisburger J. H., Weisburger E. K. Biochemical formation and pharmacological, toxicological, and pathological properties -of hydroxylamines and hydroxamic acids. Pharmacol. Rev. 1973; 25: 1–66
   PubMed Web of Science ®Google Scholar
• Weisburger J. H., Grantham P. H., Vanhorn E., Steigbigel N. H., Rall D. P., Weisburger E. K. Activation and detoxification of N-2-fluorenylacetamide i n man. Cancer Res. 1964; 24: 475–479
   PubMed Web of Science ®Google Scholar
• SRI. Species to Species Comparison of Carcinogen Metabolism. prepared for NCI by SRI, Int. 1983, 571, under contract NOI-CP-95607
   Google Scholar
• Conney A. Introduction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocar- bons. Cancer Res. 1982; 42: 4875–4917
   PubMed Web of Science ®Google Scholar
• Ehrenberg L., Osterman-Golkar G. S., Segerback D., Svensson K., Calleman C. J. Evaluation of genetic risks of alkylating agents. 111. Alkylation of hemoglobin after metabolic conversion of ethene oxide in vivo. Mutat. Res. 1977; 45(2): 175–184
   Web of Science ®Google Scholar
• Gibaldi M., Perrier D. Pharmacokinetics. Marcel Dekker, New York 1975
   Google Scholar
• Rowland M., Tozer T. N. Clinical Pharmacokinetics. Lea and Febiger, Philadelphia 1980
   Google Scholar
• Gillette J. R. Sequential organ first-pass effects: Simple methods for constructing compartmental pharmacokinetic models from physiological models of drug disposition by several organs. J. Pharmacol. Sci. 1982; 71: 673–676
   PubMed Web of Science ®Google Scholar
• Rose M. S., Smith L. L., Wyatt I. Evidence for energy- dependent accumulation of paraquat into rat lung. Nature 1974; 252: 314
   PubMed Web of Science ®Google Scholar
• Gillette J. R., Pang K. S. Theoretic aspects of pharmaco- kinetic drug interactions. Clin. Pharmacol. Therap. 1977; 22: 623–639
   PubMed Web of Science ®Google Scholar
• Levy R., Galinsky R. E., Lin J. H. Pharmacokinetic conse- quences and toxicologic implications of endogenous cosubstrate depletion. Drug Metab. Rev. 1982; 13: 1009–1020
   PubMed Web of Science ®Google Scholar
• Gillette J. R., Saul W. F., Maling H. A new principle for estimating hepatic blood flow. Pharmacology 1981; 23: 237–246
   PubMed Web of Science ®Google Scholar
• Gillette J. R. Effects of Induction of cytochrome P-450 enzymes on the concentration of foreign compounds and their metabolites and on the toxicologlcal effects of these compounds. Drug Metab. Rev. 1979; 10: 59–87
   PubMed Web of Science ®Google Scholar
• Pang K. S., Gillette J. R. Sequential first-pass elimination of a metabolite derived from a precursor. J. Pharmacol. Biopharmacol. 1979; 7: 275–290
   PubMedGoogle Scholar
• Gillette J. R. Solvable and Unsolvable Problems in Extrapolating Toxicologlcal Data Between Animal Species and Strains. Drug Metabolism and Drug Toxicity, J. R. Mitchell, M. G. Horning. Raven, New York 1984; 237–260
   Google Scholar
• Farber E. Mechanisms by which chemicals initiate cancer. J. Clin. Pharmacol. 1975; 15: 24–28
   Web of Science ®Google Scholar
• Miller J. A., Miller E. C. Metabolic activation and reactivity of chemical carcinogens. Mutat. Res. 1975; 33: 25–26
   PubMed Web of Science ®Google Scholar
• Welsburger E. K. Mechanisms of chemical carcinogenesis. Ann. Rev. Pharmacol. Toxicol. 1978; 18: 395–415
   PubMed Web of Science ®Google Scholar
• Farber E. Chemical carcinogenesis. A biologic perspective. Am. J. Pathol. 1982; 106: 271–296
   PubMed Web of Science ®Google Scholar
• Clayson D. B. Carcinogens and carcinogenesis enhancers. Mutat. Res. 1981; 86: 217–229
   PubMed Web of Science ®Google Scholar
• Majesky M. W., Yang H-Y. L., Benditt E. P., Juchau M. R. Carcinogenesis and atherogenesis: Differences in monooxy-genase induclbllity and bioactivation of benzo(a)pyrene in aortic and hepatic tissues of atherosclerosis-susceptible versus resistant pigeons. Carcinogenesis 1983; 4: 647–652
   PubMed Web of Science ®Google Scholar
• Albert R., Vanderlaan M., Burns F., Nishlzumi M. Effect of carcinogens on chicken atherosclerosis. Cancer Res. 1977; 27: 2232–2235
   Google Scholar
• Bond J. A., Gown A. M., Yang H-Y. L., Benditt E. P., Juchau M. R. Further investigations on the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. J. Toxicol. Env. Health 1981; 7: 327–336
   PubMed Web of Science ®Google Scholar
• Penn A., Batastinl G., Soloman J., Burns F., Albert R. Dose-resistant size increases of aortic lesions following chronic exposure to 7,12-dimethylbenz[a]anthracene. Cancer Res. 1981; 41: 588–592
   PubMed Web of Science ®Google Scholar
• Frank L. Superoxide dismutase and lung toxicity. Trends Pharmacol. Sci. 1983; 4: 124–128
   Web of Science ®Google Scholar
• Nakayama T., Kimura T., Kodama M., Nagata C. Generation of hydrogen peroxide and superoxide anion from active metabolites of naphthylamines and aminoazo dyes: Its possible role in carcinogenesis. Carcinogenesis 1983; 4: 765–769
   PubMed Web of Science ®Google Scholar
• Loganl J. K., Solankl V., Slaga T. J. Effect of tumor promoters on lipid peroxidation In mouse skin. Carcinogenesis 1982; 3: 1303–1306
   PubMed Web of Science ®Google Scholar
• Burton G. W., Ingold K. U. Beta-carotene: An unusual type of lipid antioxidant. Science 1984; 224: 569–573
   PubMed Web of Science ®Google Scholar
• Pitot H. C., Sirica A. E. The stages of initiation and promotion in hepatocarcinogenesls. Biochim. Biophys. Acta 1980; 605: 191–215
   PubMed Web of Science ®Google Scholar
• Stott W. T., Reitz R. H., Shumann A. M., Watanabe P. G. Genetic and nongenetlc events in neoplasia. Food Cosmet. Toxicol. 1981; 18: 567–576
   Google Scholar
• Hart R. W., Chang M. J.W. Interspecies differences In the removal of DNA adducts. J. Am. Coll. Toxicol. 1983; 2: 7–17
   Google Scholar
• Goldstein B. D., Witz G., Amoruso M., Troll W. Protease Inhibitors antagonize the activation of polymorphonuclear leukocyte oxygen consumption. Biochem. Biophys. Res. Comm. 1979; 88(3)854–860
   PubMed Web of Science ®Google Scholar
• Kensler T. W., Bush D. M., Kozumbo W. J. Inhibition of tumor promotion by a biomimetic superoxide dismutase. Science 1983; 221: 75–77
   PubMed Web of Science ®Google Scholar
• Kinsella A. R. H., St., Gainer C., Butter J. Investigation of a possible role for superoxide anion production in tumor promotion. Carcinogenesis 1983; 4: 717–719
   PubMed Web of Science ®Google Scholar
• Fischer S. M., Mills G. D., Slaga T. J. Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism. Carcinogenesis 1982; 3: 1243–1245
   PubMed Web of Science ®Google Scholar
• Verma A. K., Rice H. M., Boutwell R. K. Prostaglandins and skin tumor promotion: Inhibition of tumor promoter-induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesis. Biochem. Biophys. Res. Comm. 1977; 79: 1160–1166
   PubMed Web of Science ®Google Scholar
• Feinberg A. P., Vogelsteln B. Hypomethylatlon distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89–92
   PubMed Web of Science ®Google Scholar
• Wilson V. L., Jones P. A. DNA methylation decreases in aging but not in Immortal cells. Science 1983; 220: 1055–1057
   PubMed Web of Science ®Google Scholar
• Genes gone awry, Clues to cancer mechanism found. Chem. Eng. News January 17, 1983; 8
   Google Scholar
• Yunls J. J. The chromosomal basis of human neoplasia. Science 1983; 221: 227–236
   PubMed Web of Science ®Google Scholar
• Land H., Parada L. F., Weinberg R. A. Cellular oncogenes and multistep carcinogens. Science 1983; 222: 771–778
   PubMed Web of Science ®Google Scholar
• Menzel D. B., McClellan R. O. Toxic Responses of the Respiratory System. Toxicology, J. Doull, CD. Klassen, M. O. Amdur. Macmillan, New York 1980; 246–274
   Google Scholar
• Boyd M. R. Biochemical mechanisms in chemical-Induced lung injury: Roles of metabolic activation. CRC Crlt. Rev. Toxicol. 1980; 7(2)103–176
   PubMed Web of Science ®Google Scholar
• Weiss J. W., Drazen J. M., Coles N., McFadden E. R., Jr., Weller P. F., Corey E. J., Lewis R. A., Austen K. F. Bronchocon-strictor effects of leukotriene C in humans. Science 1982; 216: 196–198
   PubMed Web of Science ®Google Scholar
• Goetzl E. J. Leukocyte recognition and metabolism of leuko-trienes. Fed. Proc. 1983; 42: 3128–3131
   PubMedGoogle Scholar
• Sporn M. B., Squire R. A., Brown C. C., Smith J. M., Wenk M. L., Springer S. 13-cis-retinoic acid: Inhibition of bladder carcinogenesis in the rat. Science 1977; 195: 487–489
   PubMed Web of Science ®Google Scholar
• Chu E. W., Malmgren R. A. An inhibitory effect of vitamin A on the induction of tumors of forestomach and cervix in the Syrian hamster by carcinogenic polycyclic hydrocarbons. Cancer Res. 1965; 25(6): 884–895
   Web of Science ®Google Scholar
• Saffiottl U., Montesano R., Sellakumar A. R., Borg S. A. Experimental cancer of the lung. Inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumors. Cancer 1967; 20: 857–864
   PubMed Web of Science ®Google Scholar
• Rieder A., Adamek M., Wrba H. Delay of diethylnitrosamine-induced hepatoma in rats by carrot feeding. Oncology 1983; 40: 120–123
   PubMed Web of Science ®Google Scholar
• Sporn M. B., Roberts A. B. Role of retinoids in differentiation and carcinogenesis. Cancer Res. 1983; 43: 3034–3040
   PubMed Web of Science ®Google Scholar
• Haber S. L., Wissler R. W. Effect of vitamin E on carcinogenicity of methylcholanthrene. Proc. Soc. Exp. Biol. Med. 1962; 111: 774–775
   Web of Science ®Google Scholar
• Jaffe W. G. Influence of wheat germ oil on production of tumors in rats by methylcholanthrene. Exp. Med. Surg. 1946; 4: 278–282
   PubMedGoogle Scholar
• Miller J. A., Miller E. C. The carcinogenic aminoazo dyes. Adv. Cancer Res. 1953; j: 339–396
   Google Scholar
• Yamamoto R. S. Effect of vitamin B12-deficiency in colon carcinogenesis. Proc. Soc. Exp. Biol. Med. 1980; 163(3): 350–353
   Web of Science ®Google Scholar
• Farber E. Ethionine carcinogenesis. Adv. Cancer Res. 1963; 7: 383–474
   PubMed Web of Science ®Google Scholar
• Kawachi T., Hirata Y., Sugimura T. Enhancement of n-nltrosodlethylamlne hepatocarcinogenesls by L-tryptophan In rats. Gann 1968; 59(6)523–525
   PubMedGoogle Scholar
• Evarts R. P., Brown C. A. Effect of L-tryptophan on diethylnitrosamine and 3′-methyl-4-N-dimethylamlnoazobenzene hepatocarcinogenesls. Food Cosmet. Toxicol. 1977; 15(5): 431–435
   Google Scholar
• Evarts R. P., Mostafa M. H. The effect of L-tryptophan and certain other amino acids on liver nitrosodimethylamine demethylase activity. Food Cosmet. Toxicol. 1978; 16(6)585–589
   PubMedGoogle Scholar
• Dunning W. F., Curtis M. R. Further studies on the relation of dietary tryptophan to the Induction of neoplasm in rats. Cancer Res. 1954; 14(4)299–302
   PubMed Web of Science ®Google Scholar
• Wattenberg L. W. Inhibition of chemical carcinogenesis. J. Natl. Cancer Inst. 1978; 60(1)11–18
   PubMed Web of Science ®Google Scholar
• Ulland B. M., Weisburger J. H., Yamamoto R. S., Weis-burger E. K. Antioxidants and carcinogenesis: Butylated hydroxy-toluene, but not diphenyl-p-phenylenediamine, Inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamlde in rats. Food Cosmet. Toxicol. 1973; 11: 199–207
   PubMedGoogle Scholar
• Ross M. H., Bras G. Tumor Incidence patterns and nutrition in the rat. J. Nutr. 1965; 87: 245–260
   PubMed Web of Science ®Google Scholar
• Tucker M. J. The effect of long-term food restriction on tumours in rodents. Int. J. Cancer 1979; 2(6)803–807
   Google Scholar
• Welndruch R., Walford R. L. Dietary restrictions in mice beginning at 1 year of age: Effect on life-span and spontaneous cancer incidence. Science 1982; 215(215): 1415–1418
   Web of Science ®Google Scholar
• Shay H., Harris C., Gruenstein M. Influence of sex hormones on incidence and form of tumors produced In male and female rats by gastric instillation of methylcholanthrene. J. Natl. Cancer Inst. 1952; 13: 307–331
   PubMed Web of Science ®Google Scholar
• Huggins C., Briziarelll G., Sutton H. Rapid Induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J. Exp. Med. 1959; 109(1)25–42
   PubMed Web of Science ®Google Scholar
• Toh Y-C. Physiological and biochemical reviews of sex differences and carcinogenesis with particular reference to the liver. Adv. Cancer Res. 1973; 18: 155–209
   PubMedGoogle Scholar
• Yamamoto R. S., Weisburger E. K. The role of hormones on digestive and urinary tract carcinogenesis. Recent Progr. Hormone Res. 1977; 33: 617–653
   Google Scholar
• Lotlikar P. D., Enomoto M., Miller J. A., Miller E. C. Species variations In the N- and ring-hydroxylation of 2-acetylarainofluorene and effects of 3-methylcholanthrene pretreatment. Proc. Soc. Exp. Biol. Med. 1967; 125: 341–346
   PubMed Web of Science ®Google Scholar
• Enomoto M., Miyake M., Sato K. Carcinogenicity in the hamster of simultaneously administered 2-acetamidofluorene and 3-methylcholanthrene. Gann 1968; 59(3): 177–186
   Google Scholar
• Flala E. S., Kulakis C., Christiansen G., Welsburger J. H. Inhibition of the metabolism of the colon carcinogen, azoxy-methane, by pyrazole. Cancer Res. 1978; 28(12)4515–4521
   Google Scholar
• Lacassagne A., Buli-Hol N. P., Rudali G. Inhibition of the carcinogenic action produced by a weakly carcinogenic hydrocarbon on a highly active carcinogenic hydrocarbon. Br. J. Exp. Pathol. 1945; 26(1)5–12
   Web of Science ®Google Scholar
• Rlegel B., Wartman W. B., Hill W. T., Reeb B. B., Shublk P., Stranger D. W. Delay of methylcholanthrene skin carcinogenesis in mice by 1,2;5,6-dibenzofluorene. Cancer Res. 1951; 11(5): 301–303
   Web of Science ®Google Scholar
• Hill W. T., Stanger D. W., Pizzo A., Rlegel B., Shublk P., Wartman W. B. Inhibition of 9,10-dimethyl-l,2-benzanthracene skin carcinogenesis in mice by polycyclic hydrocarbons. Cancer Res. 1951; 11(11): 892–897
   Web of Science ®Google Scholar
• Crabtree H. G. Some effects of aromatic hydrocarbons on sulfur metabolism and tumor Induction in mice. Cancer Res. 1946; 6: 553–559
   PubMed Web of Science ®Google Scholar
• Huh T. Y., McCarter J. A. Phenanthrene as an anti-initiating agent. Br. J. Cancer 1960; 14(3)591–595
   PubMed Web of Science ®Google Scholar
• Huggins C., Grand L., Fukunishi R. Aromatic influences on the yields of mammary cancers following administration of 7,12-dimethylbenz(a)anthracene. Proc. Nat. Acad. Scl. USA 1964; 51: 737–742
   PubMed Web of Science ®Google Scholar
• Lijinsky W., Cefis F., Garcia H., Safflotti U. Skin tumorigenesis by dibenz[a,h]anthracene modified by Its hydrogenated derivatives. J. Natl. Cancer Inst. 1965; 34: 7–12
   PubMed Web of Science ®Google Scholar
• Crabtree H. G. The relative carcinogenic activity of six isomeric aminoazotoluenes. Br. J. Cancer 1949; 3(3)387–398
   PubMed Web of Science ®Google Scholar
• Crabtree H. G. Retardation of azo-carcinogenesls by non-carcinogenic azo-compounds. Br. J. Cancer 1955; 9(2)310–319
   PubMed Web of Science ®Google Scholar
• Puron R., Flrmlnger H. I. Protection against Induced cirrhosis and hepatocellular carcinoma In rats by chloramphenicol. J. Natl. Cancer Inst. 1965; 35(1)29–37
   PubMed Web of Science ®Google Scholar
• Oster W. F., Firminger H. I., Morrison D. M. Inhibition of N-2-fluorenyldiacetamide Induced hepatic carcinogenesis in rats by chloramphenicol: A dose-related phenomenon with reduced protein binding of carcinogen. Yale J. Biol. Med. 1971; 43(4–5): 297–306
   Web of Science ®Google Scholar
• Yamamoto R. S., Glass R. M., Frankel H. H., Weisburger E. K., Weisburger J. H. Inhibition of the toxicity and carcinogenicity of N-2-fluorenylacetamide by acetanilide. Toxicol. Appl. Pharmacol. 1968; 13: 108–117
   Web of Science ®Google Scholar
• Yamamoto R. S., Frankel H. H., Weisburger J. H. Effects of isomers of acetotoluidide and aminobenzoic acid on the toxicity and carcinogenicity of N-2-fluorenylacetamide. Toxicol. Appl. Pharmacol. 1970; 17: 98–106
   PubMed Web of Science ®Google Scholar
• Evarts R. P., Brown C. A. 2,4-diaminoanlsole-induced thyroid pigmentation in rats inhibited by m-phenylenediamine. Toxicol. Lett. 1981; 8(4–5): 257–264
   Web of Science ®Google Scholar